NC

Naveen Chandara Suteri

Active Director Director DIN 08713635
DIN 08713635 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Feb 2020
Shareholding value •••• Premium profile

About Naveen Chandara Suteri

Data last updated:

Naveen Chandara Suteri is a Director at Welnex Bio Private Limited (since 2020), Director at Iretus Biotech Private Limited (since 2021) and Director at Medplex Biotech Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Pharma, Chemicals and Food And Beverages. The 4 current companies with reported revenue have a combined latest revenue of ₹7.49 Cr; the largest is Welnex Bio Private Limited at ₹3.42 Cr (FY 2025). Earlier, Naveen Chandara Suteri was a Director at Stevels Pharma Limited (2021–2023).

DIN 08713635
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2020
Oldest Company Age 6 yrs
Largest company Welnex Bio Private Limited · ₹3.42 Cr (FY 2025)
Combined revenue ₹7.49 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Welnex Bio Private Limited U24290HR2020PTC085658
Director28 Feb 20202020₹3.42 Cr (FY 2025)Active
Iretus Biotech Private Limited U24290HR2021PTC099958
Director16 Dec 20212021₹2.14 Cr (FY 2025)Active
Medplex Biotech Private Limited U24302HR2022PTC102977
Director20 Apr 20222022₹1.05 Cr (FY 2025)Active
Zenio Biotech Private Limited U24303HR2020PTC091396
Managing Director05 Dec 20202020₹88.1 Lakh (FY 2024)Active
Nedulix Biotech Private Limited U24290CH2021PTC044080
Director09 Dec 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stevels Pharma Limited U24230CH2004PLC027156
Director14 Dec 20212004₹52.4 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Naveen Chandara Suteri

Directorship timeline

Open interactive timeline →
Nedulix Biotech Private Limited
Welnex Bio Private Limited
Iretus Biotech Private Limited
Medplex Biotech Private Limited
Premium access

Shareholding and investment profile for Naveen Chandara Suteri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Chandara Suteri

Naveen Chandara Suteri currently holds 5 directorships: Welnex Bio Private Limited (Director, since 28 Feb 2020, revenue ₹3.42 Cr (FY 2025)); Iretus Biotech Private Limited (Director, since 16 Dec 2021, revenue ₹2.14 Cr (FY 2025)); Medplex Biotech Private Limited (Director, since 20 Apr 2022, revenue ₹1.05 Cr (FY 2025)); Zenio Biotech Private Limited (Managing Director, since 05 Dec 2020, revenue ₹88.1 Lakh (FY 2024)); Nedulix Biotech Private Limited (Director, since 09 Dec 2021).

Naveen Chandara Suteri was first appointed on 28 Feb 2020 as Director at Welnex Bio Private Limited. The most recent appointment on record is 20 Apr 2022 at Medplex Biotech Private Limited.

The 4 current companies of Naveen Chandara Suteri that report revenue have a combined latest revenue of ₹7.49 Cr: Welnex Bio Private Limited ₹3.42 Cr (FY 2025); Iretus Biotech Private Limited ₹2.14 Cr (FY 2025); Medplex Biotech Private Limited ₹1.05 Cr (FY 2025); Zenio Biotech Private Limited ₹88.1 Lakh (FY 2024).

Naveen Chandara Suteri held 1 earlier board appointment: Stevels Pharma Limited (Director, 14 Dec 2021 to 20 Jun 2023).

The current boards of Naveen Chandara Suteri's companies include Ashish Verma (Welnex Bio Private Limited), Ram Mahajan (Welnex Bio Private Limited), Arun Kumar (Iretus Biotech Private Limited), Priya Verma (Medplex Biotech Private Limited), Richa Chouhan (Zenio Biotech Private Limited), Neha (Nedulix Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available